Shi RL - Search Results

1

[Expression of Ezrin in gastric carcinoma and its significance].

Shi RL, Li JF, Qu Y, Chen XH, Gu QL, Zhu ZG, Liu BY. Shi RL, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2006 Sep;9(5):433-5. Zhonghua Wei Chang Wai Ke Za Zhi. 2006. PMID: 17043968 Chinese.

2

[Value of ligating the middle colic artery from the root in radical surgical treatment of right hemicolon cancer].

Li DH, Shi RL, Huang L, Zhao R, Zhang HB. Li DH, et al. Among authors: shi rl. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 May;12(3):261-3. Zhonghua Wei Chang Wai Ke Za Zhi. 2009. PMID: 19434534 Chinese.

3

miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transition.

Zhang Z, Liu S, Shi R, Zhao G. Zhang Z, et al. Cancer Genet. 2011 Sep;204(9):486-91. doi: 10.1016/j.cancergen.2011.07.004. Cancer Genet. 2011. PMID: 22018270

4

Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer.

Shi R, Liu W, Liu B, Xu Z, Chen L, Zhang Z. Shi R, et al. Oncol Rep. 2013 Oct;30(4):1883-9. doi: 10.3892/or.2013.2662. Epub 2013 Aug 7. Oncol Rep. 2013. PMID: 23933755

5

Knockdown of Slit2 promotes growth and motility in gastric cancer cells via activation of AKT/β-catenin.

Shi R, Yang Z, Liu W, Liu B, Xu Z, Zhang Z. Shi R, et al. Oncol Rep. 2014 Feb;31(2):812-8. doi: 10.3892/or.2013.2887. Epub 2013 Dec 2. Oncol Rep. 2014. PMID: 24297051

6

Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer.

Shi RL, Qu N, Liao T, Wang YL, Wang Y, Sun GH, Ji QH. Shi RL, et al. Int J Oncol. 2016 May;48(5):2055-62. doi: 10.3892/ijo.2016.3412. Epub 2016 Mar 2. Int J Oncol. 2016. PMID: 26935705

7

Increased number of negative lymph nodes is associated with improved survival outcome in node positive gastric cancer following radical gastrectomy.

Shi RL, Chen Q, Ding JB, Yang Z, Pan G, Jiang D, Liu W. Shi RL, et al. Oncotarget. 2016 Jun 7;7(23):35084-91. doi: 10.18632/oncotarget.9041. Oncotarget. 2016. PMID: 27147564 Free PMC article.

8

BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer.

Liao T, Qu N, Shi RL, Guo K, Ma B, Cao YM, Xiang J, Lu ZW, Zhu YX, Li DS, Ji QH. Liao T, et al. Among authors: shi rl. Oncotarget. 2017 Jan 3;8(1):238-247. doi: 10.18632/oncotarget.10825. Oncotarget. 2017. PMID: 27462868 Free PMC article.

9

Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.

Shi RL, Qu N, Luo TX, Xiang J, Liao T, Sun GH, Wang Y, Wang YL, Huang CP, Ji QH. Shi RL, et al. Thyroid. 2017 Apr;27(4):537-545. doi: 10.1089/thy.2016.0228. Epub 2017 Jan 24. Thyroid. 2017. PMID: 27825291

10

[Risk for metastasis of lymph node between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer].

Sun GH, Qu N, Hu JQ, Shi RL, Zhang TT, Wen D, Wang YL, Wang Y, Zhu YX, Ji QH. Sun GH, et al. Among authors: shi rl. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Apr 7;52(4):253-258. doi: 10.3760/cma.j.issn.1673-0860.2017.04.003. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28441800 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters